A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Gujarat has outperformed the national average (93.23 per cent) in the SDG-3 Index, achieving 95.95 per cent vaccination ...

The Serum Institute of India, ImmunityBio’s collaboration partner, is the world’s largest manufacturer of vaccines by volume. In bladder cancer clinical trials in Europe, the recombinant BCG ...

Michigan has the only persisting bovine tuberculosis outbreak in wild deer anywhere in the U.S. — and it occasionally spills ...

The only licensed vaccine on the market—the Bacille Calmette-Guerin (BCG) vaccine—was invented more than 100 years ago and ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

By Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.